Back
Loncar Cancer Immunotherapy ETF Stock Price Chart
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
50
CNCR
Loncar Cancer Immunotherapy ETF
Last Price:
15.44
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight buying pressure.
Loncar Cancer Immunotherapy ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.56 | Buy |
| 20-day SMA: | 14.96 | Buy |
| 50-day SMA: | 15.92 | Sell |
| 200-day SMA: | 13.07 | Buy |
| 8-day EMA: | 14.78 | Buy |
| 20-day EMA: | 14.98 | Buy |
| 50-day EMA: | 15.24 | Buy |
| 200-day EMA: | 14.03 | Buy |
Loncar Cancer Immunotherapy ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 53.47 | Buy |
| Chaikin Money Flow: | 10239 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.42 - 15.98) | Buy |
| Bollinger Bands (100): | (13.37 - 16.39) | Buy |
Loncar Cancer Immunotherapy ETF Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Loncar Cancer Immunotherapy ETF Stock
Is Loncar Cancer Immunotherapy ETF Stock a Buy?
- Loncar Cancer Immunotherapy ETF share price is 15.44 while CNCR 8-day simple moving average is 14.56, which is a Buy signal.
- The stock price of CNCR is 15.44 while Loncar Cancer Immunotherapy ETF 20-day SMA is 14.96, which makes it a Buy.
- Loncar Cancer Immunotherapy ETF 50-day simple moving average is 15.92 while CNCR share price is 15.44, making it a Sell technically.
- CNCR stock price is 15.44 and Loncar Cancer Immunotherapy ETF 200-day simple moving average is 13.07, creating a Buy signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
50
Loncar Cancer Immunotherapy ETF (CNCR)
is a Sell
Is Loncar Cancer Immunotherapy ETF a Buy or a Sell?
-
Loncar Cancer Immunotherapy ETF stock is rated a Sell
The current Loncar Cancer Immunotherapy ETF [CNCR] share price is $15.44. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Loncar Cancer Immunotherapy ETF Stock Info
Market Cap:
0
Price in USD:
15.44
Share Volume:
82.84K
Loncar Cancer Immunotherapy ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
9.22
Sell
50
Loncar Cancer Immunotherapy ETF (CNCR)
is a Sell
Loncar Cancer Immunotherapy ETF Share Price Forecast
-
What is the Loncar Cancer Immunotherapy ETF stock price today?
The Loncar Cancer Immunotherapy ETF stock price is 15.44 USD today. -
Will CNCR stock go up or go down?
Loncar Cancer Immunotherapy ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Loncar Cancer Immunotherapy ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Loncar Cancer Immunotherapy ETF is overvalued.
Is Loncar Cancer Immunotherapy ETF Stock a Buy?
- Loncar Cancer Immunotherapy ETF share price is 15.44 while CNCR 8-day exponential moving average is 14.78, which is a Buy signal.
- The stock price of CNCR is 15.44 while Loncar Cancer Immunotherapy ETF 20-day EMA is 14.98, which makes it a Buy.
- Loncar Cancer Immunotherapy ETF 50-day exponential moving average is 15.24 while CNCR share price is 15.44, making it a Buy technically.
- CNCR stock price is 15.44 and Loncar Cancer Immunotherapy ETF 200-day simple moving average is 14.03, creating a Buy signal.
Technical Analysis of Loncar Cancer Immunotherapy ETF
Should I short Loncar Cancer Immunotherapy ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Loncar Cancer Immunotherapy ETF is a Sell
- Loncar Cancer Immunotherapy ETF Relative Strength Index (RSI) is 53.47, which suggest Loncar Cancer Immunotherapy ETF is overbought
- The Bollinger Bands (25) for Loncar Cancer Immunotherapy ETF is (14.42 - 15.98), which suggest Loncar Cancer Immunotherapy ETF is a Buy
- The Bollinger Bands (100) for Loncar Cancer Immunotherapy ETF is (13.37 - 16.39), which suggest Loncar Cancer Immunotherapy ETF is a Buy
* Loncar Cancer Immunotherapy ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.